Press Releases

Press Releases

Home › Investors › Press Releases

OncoSec Medical Announces Positive Interim Data from Phase 2 Study of OMS-I100 in Metastatic Melanoma

December 16, 2013

OncoSec Medical Announces Hire of Chief Medical Officer

December 12, 2013

OncoSec Medical to Present at the 6th Annual LD Micro Conference

November 26, 2013

OncoSec Medical Announces Positive Preliminary Safety Data in Combination Study

October 8, 2013

OncoSec CEO Punit Dhillon to Present at INTERFACE 2013 Digital Health Summit

October 4, 2013

OncoSec Medical to Present at the 12th Annual BIO Investor Forum

October 3, 2013

OncoSec Medical to Present at the Cancer Vaccines and Gene Therapy Meeting

October 1, 2013

OncoSec Announces Melanoma Development Strategy

September 24, 2013

OncoSec Medical to Present at the 2013 Aegis Capital Healthcare Conference

September 20, 2013

OncoSec Medical Closes $12 Million Public Offering

September 19, 2013

Copyright © 2017 OncoSec Medical. All Rights Reserved. Q12-003052-01 REV E